Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib

Overview of attention for article published in Blood, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 21 X users

patent: 13 patents
facebook: 1 Facebook page

Readers on

mendeley: 223 Mendeley

So far, Altmetric has seen 23 X posts from 21 X users, with an upper bound of 142,785 followers.

Molecular remission and response patterns in patients with mutant- IDH2 acute myeloid leukemia treated with enasidenib [Dec 3, 2018] Stein et al. @BloodJournal https://t.co/m9Ng2tA70M #NCT01915498 #PrecisionMedicine #AMLsm #leusm https://t.co/R3WjhlSFbo

RT @BloodJournal: Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid #leukemia treated with enasidenib ht…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 19 additional X posts.